What laboratory values are typically abnormal in alcoholic liver disease?

Laboratory Values in Alcoholic Liver Disease

In alcoholic liver disease, the most characteristic laboratory finding is an AST/ALT ratio >2 (and especially >3), with both aminotransferases typically elevated but rarely exceeding 300 IU/L, accompanied by elevated GGT, elevated MCV, and in advanced disease, decreased albumin, elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. 1, 2

Key Aminotransferase Pattern

The aminotransferase pattern is highly suggestive of ALD:

• AST elevation is more prominent than ALT - this is the hallmark finding
• AST/ALT ratio >2 occurs in ~70% of patients with ALD 1
• AST/ALT ratio >3 is highly suggestive of ALD and should raise strong suspicion 1, 2
• **Both AST and ALT typically remain <300 IU/L** - levels >500 IU/L for AST or >200 IU/L for ALT are uncommon and should prompt consideration of alternative diagnoses (except in alcoholic foamy degeneration or concomitant acetaminophen overdose) 1, 2
• In severe alcoholic hepatitis, AST is typically elevated 2-6 times the upper limit of normal 1

This contrasts sharply with non-alcoholic fatty liver disease where the AST/ALT ratio is typically <1 3.

Alcohol-Specific Biomarkers

Gamma-glutamyl transpeptidase (GGT):

• Elevated in ~75% of habitual drinkers 2
• Useful for monitoring abstinence as it recovers slowly after alcohol cessation 2
• Important caveat: Low sensitivity and specificity limit its usefulness as a standalone marker - can be elevated in non-alcoholic liver disease, obesity, diabetes, smoking, and drug use 1
• Combining elevated GGT with elevated MCV improves diagnostic sensitivity 1

Mean corpuscular volume (MCV):

• Elevated with heavy drinking, particularly when daily consumption exceeds 60 g 2
• Returns to normal after several months of abstinence 2
• Low sensitivity when used alone, but improves when combined with GGT 1

Carbohydrate-deficient transferrin (CDT):

• High specificity but low sensitivity 1, 2
• Influenced by age, sex, BMI, and other chronic liver diseases 1
• Not widely used in clinical practice due to limited test characteristics 2

Phosphatidylethanol (PEth):

• Most sensitive and specific biomarker available 4
• Detects single drinking episode for up to 12 days and chronic heavy use for up to 6 weeks 5, 4
• Cutoff of 20 ng/mL has 97-100% sensitivity and 66-96% specificity 4
• Cutoff of 200 ng/mL detects daily drinking up to 60 g/day 5
• Not affected by liver disease, making it preferable to other markers 4
• Increasingly used in liver transplant centers for monitoring 5, 4

Markers of Advanced Disease and Hepatic Dysfunction

As ALD progresses to cirrhosis and hepatic decompensation:

• Decreased serum albumin - reflects impaired hepatic synthetic function 2
• Elevated bilirubin - indicates hepatocellular dysfunction or cholestasis 2
• Prolonged prothrombin time/elevated INR - reflects impaired synthesis of clotting factors 2
• Thrombocytopenia (decreased platelet count) - suggests portal hypertension and hypersplenism 2

Practical Clinical Algorithm

For suspected ALD, order:

1. AST, ALT - look for AST/ALT ratio >2 (especially >3) with levels typically <300 IU/L
2. GGT and MCV - combination improves sensitivity for detecting alcohol use
3. Albumin, bilirubin, PT/INR, platelet count - assess hepatic function and disease severity
4. PEth (if available) - most accurate biomarker for recent alcohol consumption

Critical pitfall to avoid: No single laboratory marker definitively establishes alcohol as the etiology of liver disease 1. The diagnosis requires documentation of excess alcohol consumption (>40 g/day in men, >20 g/day in women) combined with evidence of liver injury 2. Always consider that alcohol may be one of multiple factors causing liver injury 1.